GGrantIndex
Sort

78,016 grants matching breast cancer

Targeting the p110beta isoform of PI3 kinase in prostate cancer

$554,053
Thomas M Roberts · Dana-Farber Cancer Inst · R01 · FY2017 · CA

INFRASRUCTURE SUPPORT AND DATA ENHANCEMENTS FOR THE CARET BIOREPOSITORY

$554,050
Gary E Goodman · Fred Hutchinson Cancer Research Center · UM1 · FY2015 · CA

In Situ Albumin Binding siRNAs for Triple Negative Breast Cancer Tumor Penetration and Molecularly Targeted Therapy

$553,948
Craig Lewis Duvall · Vanderbilt University · R01 · FY2022 · CA

ENGINEERED ERYTHROCYTES FOR PREVENTION OF DISSEMINATION OF METASTATIC BREAST CANCER

$553,860
University Of California, San Diego · · FY2010 · Department of the Army

Delineating Functional Immunity via Image-Guided PET

$553,790
Nerissa Therese Viola · Wayne State University · R37 · FY2024 · CA

Etiology and Genomics of Breast Cancer Progression in Women of African Ancestry

$553,775
Olufunmilayo I Olopade · University Of Chicago · R01 · FY2020 · MD

Promoting Breast Cancer Screening Via Computer V Phone

$553,752
Indiana Univ-Purdue Univ At Indianapolis · R01 · FY2004 · NR

Developing Methods for Precise, Safe and Target-location Specific Histotripsy of Liver Tumors

$553,734
Timothy J Ziemlewicz · University Of Wisconsin-Madison · R01 · FY2023 · CA

Minority-Based CCOP at UMDNJ-NJ Medical School/University Hospital Cancer Center

$553,640
Robert Wieder · Rbhs-New Jersey Medical School · U10 · FY2013 · CA

Cellular hierachy of ER- breast cancers in different ethnic groups

$553,639
Michael Clarke · Stanford University · U01 · FY2010 · CA

THERAPEUTIC MANUFACTURING

$553,636
Leland H Hartwell · Fred Hutchinson Cancer Research Center · P30 · FY2009 · CA

ROLE OF THE ECD A NOVEL CELL CYCLE REGULATOR IN BREAST CANCER

$553,621
Board Of Regents Of The University Of Nebraska · · FY2011 · Department of Defense

TCR signaling and cell cycle regulation in tumor-specific CD8 T cell dysfunction

$553,614
Mary Philip · Vanderbilt University Medical Center · R37 · FY2025 · CA

Overcoming hypoxic resistance to anti-cancer therapy

$553,580
Nicholas C Denko · Ohio State University · R01 · FY2024 · CA

An AI-enabled Digital Pathology Platform for Multi-Cancer Diagnosis, Prognosis and Prediction of Therapeutic Benefit

$553,532
Anant Madabhushi · Emory University · U01 · FY2023 · CA

Intensive Blood Pressure Control During Cardiotoxic Breast Cancer Treatment (PROTECT) Trial

$553,491
Anthony Francis Yu · Sloan-Kettering Inst Can Research · R37 · FY2024 · CA

The Genetic Basis of Aggressive Prostate Cancer: The Role of Rare Variation

$553,487
Christopher Alan Haiman · University Of Southern California · R01 · FY2017 · CA

Targeting Kinesin Family Member 15 for the Treatment of Cancer

$553,464
Andrew K Godwin · University Of Kansas Medical Center · R01 · FY2019 · CA

Safe and Just Cleaners: Reducing exposure to toxic cleaning chemical products among low wage immigrant Latino Community members

$553,378
Sherry L Baron · Queens College · R01 · FY2021 · ES

Minority-Based CCOP at UMDNJ-NJ Medical School/University Hospital Cancer Center

$553,351
Robert Wieder · Univ Of Med/Dent Of Nj-Nj Medical School · U10 · FY2012 · CA

Minority-Based CCOP at UMDNJ-NJ Medical School/University Hospital Cancer Center

$553,351
Robert Wieder · Univ Of Med/Dent Of Nj-Nj Medical School · U10 · FY2011 · CA

Hybrid virtual-MRI/CBCT: A new paradigm for image guidance in liver SBRT

$553,348
Lei Ren · Duke University · R01 · FY2019 · EB

CCR Genomics Core

$553,306
Kathleen Hartman · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA

Novel precision medicine approach to treatment of osteoporosis based on bone turnover

$553,303
Hartmut H Malluche · University Of Kentucky · R01 · FY2024 · AG

Novel precision medicine approach to treatment of osteoporosis based on bone turnover

$553,303
Hartmut H Malluche · University Of Kentucky · R01 · FY2023 · AG